initially reported that the expression of miR-193a-3p was elevated in chemotherapy-resistant BC cell lines (H-bc and UM-UC-3), with multiple rounds of chemotherapy resistance achieved by inhibiting the oxidative stress (OS) pathway via the lysyl oxidase-like 4 (LOXL4) gene (115). This evidence concerns the gene LOXL4 and breast cancer.